Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Single-Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of YJ001 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Safety and Tolerability
- Interventions
- Drug: YJ001 for Spray UseDrug: Placebo of YJ001 for Spray Use
- First Posted Date
- 2022-07-11
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Yuejia Pharmaceuticals (USA), Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT05451667
- Locations
- 🇺🇸
Pharmaron CPC, Inc., Baltimore, Maryland, United States
News
No news found